IGEA Pharma N.V.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of IGEA Pharma N.V. generated cash of -$401,200, which is more than the previous year. Cash used in financing activities reached the amount of $514,300 last year. Net change in cash is therefore $12,800.
Cash Flow
| 2017 | -249.45K | 0 | 223.17K |
|---|---|---|---|
| 2018 | -1.21M | 269.16K | 3.10M |
| 2019 | -1.28M | -156.40K | -54.99K |
| 2020 | -732.54K | 5 | 454.48K |
| 2021 | -1.08M | 291.8K | 645.1K |
| 2022 | -401.2K | -107.4K | 514.3K |
IGPH.SW Cash Flow Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 17.1K | 88.6K | 362.94K | 1.92M | 10.78K | 36.66K |
Operating activities | ||||||
Net income | -11.75M | -1.25M | -925.48K | -1.70M | -1.24M | -359.35K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 0 | 0 | 77.23K | 130.51K | 66.32K | 63.23K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 914.4K | -400 | -7.39K | -3.92K | 722 | -8.33K |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -401.2K | -1.08M | -732.54K | -1.28M | -1.21M | -249.45K |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | -156.40K | 0 | 0 |
Acquisitions Net | -107.4K | -155.5K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -107.4K | 291.8K | 5 | -156.40K | 269.16K | 0 |
Financing activities | ||||||
Common Stock Issued | 0 | 696.9K | 0 | 0 | 2.86M | 41.67K |
Payments for dividends | 0 | 0 | 0 | 0 | -48.35K | 0 |
Repurchases of common stock | 0 | 0 | 0 | -35.17K | -40.56K | 0 |
Repayments of term debt | 0 | -70.2K | -22.11K | 0 | -51.44K | 0 |
Cash used in financing activities | 514.3K | 645.1K | 454.48K | -54.99K | 3.10M | 223.17K |
Net Change In Cash | 12.8K | -71.5K | -253.58K | -1.52M | 1.87M | -26.38K |
Cash at end of period | 29.9K | 17.1K | 109.35K | 398.51K | 1.88M | 10.28K |
| Data source | Data source | Data source | Data source | Data source | Data source |